Vanda Pharmaceuticals
VNDA
#8785
Rank
C$0.30 B
Marketcap
C$5.07
Share price
-3.54%
Change (1 day)
-29.75%
Change (1 year)

EPS for Vanda Pharmaceuticals (VNDA)

EPS in 2026 (TTM): C-$6.42

According to Vanda Pharmaceuticals's latest financial reports the company's current EPS (TTM) is C-$6.62. In 2025 the company made an earnings per share (EPS) of C-$5.34 a decrease over its 2024 EPS that were of C-$0.46.

EPS history for Vanda Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$6.4220.11%
2025C-$5.341065.62%
2024C-$0.46-710.9%
2023C$0.07503-56.35%
2022C$0.17-80%
2021C$0.86
2019C$3.11334%
2018C$0.72-247.06%
2017C-$0.49-19.05%
2016C-$0.60-55.32%
2015C-$1.35-347.37%
2014C$0.54-156.72%
2013C-$0.96-31.63%
2012C-$1.40

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$9.57-244.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$7.52-213.64%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$1.02-115.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$44.25-768.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$1.42-121.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$6.47-197.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
C-$6.29-4.98%๐Ÿ‡บ๐Ÿ‡ธ USA